Review provides insights on pulmonary fibrosis following COVID-19 infections, highlighting diagnostic strategies and potential therapies.
Key Points
Pulmonary fibrosis significantly impacts quality of life and lung function in post-COVID-19 patients, revealing urgent need for understanding its mechanisms.
Post-COVID-19 pulmonary fibrosis affects a notable portion of recovering COVID-19 patients, emphasizing its prevalence in related conditions.
This review synthesizes clinical and experimental findings to elucidate diagnostic and mechanistic strategies for pulmonary fibrosis post-COVID-19.
Understanding these connections may enhance therapeutic strategies, highlighting the complexity of post-viral lung damage and the necessity for effective treatments.